Preservation of Ovarian Function After Hematopoietic Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin
- Status
- COMPLETED
- Phase
- N/A
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
- Status
- COMPLETED
- Phase
- N/A
FNA Tumor Sampling for CD137 Modulation: A Pilot Study
- Status
- TERMINATED
- Phase
- N/A
Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells
- Status
- COMPLETED
- Phase
- PHASE2
EMD 521873 in Advanced Solid Tumors, MTD Finding
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae
- Status
- COMPLETED
- Phase
- PHASE2
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients
- Status
- COMPLETED
- Phase
- NA